Effects of probiotics in bilirubin increase

Phase 2

• Conditions: hyperbilirubinemia.; Neonatal jaundice associated with preterm delivery; P59.0

• Registration Number: IRCT20081021001378N13
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Neonate weighting less than 2,500 grams are not in critical condition
Do not have krenictrose
Do not have ventilation
Do not have heart failure
Do not have asphyxia and no history of Rh incompatibility
Do not have icterus

Exclusion Criteria

Critical neonates
Phototherapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bilirubin. Timepoint: Daily for 7 days. Method of measurement: Through the surface of the skin.;Hospitalization period. Timepoint: Daily. Method of measurement: Number of days.

Secondary Outcome Measures

Name	Time	Method
Weight gain. Timepoint: Daily. Method of measurement: Balance.